Hon Lik is the Chinese pharmacist who invented the electronic cigarette. In 2001, while using high-dose nicotine patches to help himself stop smoking, he devised a system on a large console, using food additives as solvents. The challenge was managing to scale the mechanism down to a miniature size, suitable for a hand-held cigarette-sized device, and getting the right dose of nicotine, while also getting the right odours from additives. In 2000, he came up with the idea of using a piezoelectric ultrasound-emitting element to vaporize a pressurized jet of liquid containing nicotine diluted in a propylene glycol solution. Hon also proposed placing the liquid in a disposable plastic cartridge which serves as a reservoir and mouthpiece. These inventions are the basis of the present-day electronic cigarettes. In 2003, Hon filed the first patent in 2003 in China for the device and the first electronic cigarette was manufactured that year in Beijing, China.

Clive Bates , Counterfactual Consulting, United Kingdom

Clive Bates has had varied career having worked in the private sector for IBM, in the UK government in Tony Blair's Strategy Unit, the United Nations in Sudan, for Greenpeace and for Action on Smoking and Health in the UK, which is why he is interested in smoke free alternatives to tobacco.  Since early 2013 he has his own public interest consultancy and advocacy organisation, including the Counterfactual blog.  He is interested in the enormous public health potential of tobacco harm reduction and is not engaged by pharmaceutical, e-cigarette or tobacco interests.

Prof Linda Bauld, University of Stirling and UK Centre for Tobacco and Alcohol Studies, UK

Linda Bauld is Professor of Health Policy at the University of Stirling, Director of the Institute for Social Marketing and Deputy Director of the UK Centre for Tobacco and Alcohol Studies. She has a background in applied policy research and for the past 15 years her research interests have centred on the evaluation of public health interventions. She has conducted studies on drug and alcohol use, inequalities in health and, most notably, on tobacco control and smoking cessation. She is a former scientific adviser on tobacco control to the UK government and currently chairs a number of public health advisory and funding committees for NICE, Cancer Research UK and the Scottish government.

Patryk Bełzak, Vaper, Polish Coordinator of EFVI, co-founder of SUEP
Vaper since 09.2012, very active in fighting against new TPD regulations. Polish coordinator of European Free Vaping Iinitiative (EFVI), one of founders of SUEP (Polish Vapers Association). Absolutely in love with e-cigs, trying to spread them among smokers as much as possible. Also owner of small online e-cigarettes store.

Dr Clark is Vice President of Regulatory and Scientific Affairs at Philip Morris International where he leads PMI’s global efforts to attain regulatory approval and marketing authorization for Reduced Risk Products (RRPs). In this role he also has oversight of PMI’s RRP external scientific engagement activities for RRPs within the regulatory, public health and scientific communities. Dr Clark is also involved in defining and setting the R&D strategy for RRP Quality Assurance activities to ensure that PMI’s RRP efforts anticipate and meet evolving global regulatory requirements. Prior to joining PMI in January 2013, Dr Clark had over 25 years of clinical and regulatory experience in the pharmaceutical industry, working in both branded and generic industries dealing with development and regulatory challenges for complex therapeutics such as; formulations of second entry inhaled corticosteroids, peptides and biosimilars. Most recently, he served as Senior Vice President of Scientific and Regulatory Affairs at Apotex Inc., with global responsibility for regulatory affairs, pharmacovigilance, project management and R&D Quality Assurance.

Dr Attila Danko is an experienced, busy General Practitioner in Ballarat, a regional city in Australia.  Over the last few years, several of his patients have surprised him by being able to give up smoking using electronic cigarettes when all other methods had failed.  Inspired by the potential revolution in smoking cessation this represents, and appalled by the prohibitionist policies of his country, he began to advocate for the liberalisation of laws in Australia that effectively ban nicotine containing electronic cigarettes.  He recieves no payment or any inducement whatsoever from any Pharmaceutical, Tobacco or Electronic cigarette company.  He is in the preliminary stages of working with Professor Ron Borland, Nigel Gray Distinguished Fellow in Cancer Prevention at Cancer Council Victoria, Australia, on an upcoming study on electronic cigarettes.

Martin Dockrell Tobacco Control Lead, Public Health England, London
Martin has been involved in public health since the mid 1980's. He started in community based responses to HIV/AIDS and moved through respiratory health and patient advocacy to tobacco control. He is former Director of Policy & Research at Action on Smoking and Health.

Carmen received PhD in Cell Biology and Genetics at the Autonoma University of Madrid, has developed her researcher activity at the Spanish National Institute of Agrarian Research and Technology (INIA) and in the College of Veterinary Medicine at the University of Maryland (USA) participating in several research projects in molecular virology. As a provaping activist, she is EFVI Spain and MOVE (Medical Organizations Supporting Vaping and Electronic cigarettes) promoter and coordinator. She is founder and scientific advisor for several Spanish associations related to eCig, attended or collaborated at several symposiums and conferences such as GFN 2014, ICO-WHO Symposia on Tobacco Control or e-Cigarette SUMMIT 2014, and has written several reports for different associations and online publications. She has recently been included in the Spanish Committee of experts to regulate the quality and safety electronic cigarettes European standards, under the European Committee for Standardization (CEN).

Dr Konstantinos Farsalinos , Onassis Cardiac Surgery Center, Athens, Greece

Dr Konstantinos Farsalinos is a cardiologist, working as researcher at Onassis Cardiac Surgery Center in Athens-Greece and at Medical Imaging Research Center, University Hospital Gathuisberg in Leuven-Belgium. His main research interests are new modalities in cardiovascular imaging and he has received a scholarship from the Greek Society of Cardiology for research and education in this field. He has studied the effects of smoking on subclinical cardiac dysfunction using new imaging techniques since 2010.

He has been actively performing research on electronic cigarettes since 2011 as a principle investigator, in both clinical and laboratory level. Examples of his work include the first study on the cytotoxic effects of electronic cigarette vapor on cultured cells and the immediate effects of electronic cigarettes used on cardiac function and coronary circulation. He has presented his research in major international scientific congresses and has published more than 15 studies and letters about e-cigarettes in peer-reviewed medical journals.

Joseph (Joe) G. Gitchell serves as President at PinneyAssociates, with responsibility for client service, and leads the Marketing Strategy team. Mr. Gitchell leads efforts supporting regulatory approvals, conducting public policy analysis, developing marketing approaches, devising, refining and defending claims (including extensive claims challenge support) and providing input on strategic market opportunities and directions.  He has worked for clients in the US, Europe, Latin America, Asia and the Middle East. This work has included extensive collaboration with researchers and policy experts around the world.

A co-author on almost 40 articles, Mr. Gitchell has been published in journals including Tobacco Control, Preventive Medicine, Addiction, Archives of Internal Medicine and Morbidity and Mortality Weekly Report.

Dr Mareva Glover works at the University of Auckland’s Centre for Tobacco Control Research. Since her award-winning doctoral research on Māori smoking cessation in 2000, she has led and supported many tobacco control and Māori health research projects. Dr Glover has been trying to help smokers quit the habit for more than 17 years.

Her project WERO is a group stop smoking contest that uses iPad and iPhone apps to get teams of people quitting smoking together, and is just one intervention aimed at halving the number of Māori and Pacific smokers by 2020. The project was one of 12 to qualify for the Spark $100K Challenge in 2011. It is based on Māori and Pacific cultural values, focusing on teams rather than individuals, and uses non-smokers or ex-smokers as coaches.

Jack Henningfield is Vice President, Research, and Health Policy at PinneyAssociates, and Adjunct Professor of Behavioral Biology, in the Department of Psychiatry and Behavioral Sciences at The Johns Hopkins University School of Medicine. He served on FDA’s first Tobacco Products Scientific Advisory Committee (TPSAC) from 2010 to 2011, and the World Health Organization’s first Tobacco Regulation Study Group and its predecessor the Scientific Advisory Committee on Tobacco Regulation from 2000 to 2014. Before PinneyAssociates, he headed the Clinical Pharmacology Branch of the National Institute on Drug Abuse (NIDA) where he regularly advised  the FDA on matters concerning abuse and dependence liability of a broad range of drugs and regulatory challenges including tobacco and nicotine products and FDA’s proposed Tobacco Regulation.

Terry Hu is the leader of CECMOL, which is China's largest E-cigarette industry portal and mobile information platform. He is a social observer and promoter committed to human health and high quality of life, the founder of China's first CECMOL E-cigarette Forum, and the organizer of China's first CECMOL Vapor Expo. He contacts the relevant Chinese government departments and tobacco companies, organizes and promotes the discussion and setting of China's E-cigarette industry standards. He expands the influence and cognition of E-cigarette in consumers to reduce the harm from consuming tobacco, and strives for improving the quality of life for Chinese people.

Lorien Jollye is a mother of 3, an ex smoker of 23 years and a Vaper since 2012. After numerous, unsuccessful, quit attempts utilising most all the market had to offer, and smoking through two pregnancies, she found that e-cigarettes enabled her to switch her habit entirely, in one day. Since then, she has been a vocal advocate, volunteering with the Consumer Association and latterly, The New Nicotine Alliance, along with other passionate vapers. It has become a simple message, Nothing About Us Without Us.

Vaidotas Linkevičius is an expert in EU policy-making currently advising large multinational companies on EU taxation policy, financial services/consumer credit affairs, data protection, digital single market issues.
From 2007, he was Attaché for Fiscal Affairs at the Permanent Representation of Lithuania in Brussels dealing with a wide variety of EU tax files (VAT; Excises on tobacco, alcohol and energy; CIT; PIT, Administrative cooperation). During the Lithuanian EU Presidency in 2013 he was one of the main designers of the tax agenda for the Presidency. Vaidotas chaired EU Council Working Groups on tax issues and financial services dossiers covering highly political issues and technically complex topics.

Prof Karl Lund, Norwegian Institute for Alcohol and Drug Research (SIRUS), Norway

Research Director at the Norwegian Institute for Alcohol and Drug Research since 2006. He has been involved in tobacco control work since the mid 1980s, working at the Norwegian Council on Tobacco or Health (Deputy Leader), the Norwegian Institute for Public Health (Researcher), and the Norwegian Cancer Society (Director for Department of Cancer Prevention). Dr. Lund received the Norwegian Medical Association’s Award in preventive medicine in 2002. He is well published within tobacco research, has been a lecturer on tobacco topics in several countries worldwide, and has been a member of several expert committees on tobacco control including WHO’s International Agency for Cancer Research (IARC) and the executive committee of the International Society for the Prevention of Tobacco Induced Diseases. He has also been an expert witness for the plaintiff in tort liability lawsuits brought before the Norwegian Supreme Court against the tobacco industry. Dr. Lund has been associate editor in the scientific journal Nicotine & Tobacco Research since 2011.

Professor Ann McNeill is a British academic and tobacco policy expert. She is currently a Professor of Tobacco Addiction in the National Addictions Centre at the King's College London Institute of Psychiatry, Psychology & Neuroscience and Deputy Director of the UK Centre for Tobacco and Alcohol Studies.
McNeill has devoted her career to reducing the harmfulness of smoking to individuals and society and has worked in prevention, cessation and harm reduction, in particular how to reduce the health inequalities caused by smoking. McNeill is a Council member of Action on Smoking and Health and is a trustee of the Society for the Study of Addiction and of Tobacco Free Futures.

Barnaby Page, EcigIntelligence, UK

Barnaby is a journalist with 30 years’ experience including roles at Media Week, aka.tv, TechWeb.com, and Casino International; he has been a reporter and editor on numerous magazines and broadsheet newspapers in Britain, Canada and the Middle East, specialising in business, technology/innovation, marketing and regulation.

Prof Riccardo Polosa, Prof Riccardo Polosa , University of Catania, Italy

Director of the Institute for Internal and Emergency Medicine of the University of Catania in Italy. He is also in charge of the University's Centre for Tobacco Research (CPCT), and Honorary Professor of Medicine at Southampton University (UK). He is author of more than 250 peer reviewed articles and books mainly covering respiratory medicine, clinical immunology, and tobacco addiction.

On top of his academic work, he serves also as chief scientific advisor for Lega Italiana Anti Fumo (LIAF), the Italian Anti-Smoking League. Prof Polosa's and his research team have lead several clinical trials on e-cigarettes.

John is Scientific Regulatory Liaison Manager with Imperial Tobacco Limited, based in the UK, where he is responsible for a team of regulatory scientists and commissions studies to advance knowledge relevant to current regulatory issues. John has a background in Pharmacology and Toxicology, and was previously a Toxicologist for a UK Public Health Agency and has also worked in Pre-Clinical Safety Assessment at an International Contract Research Organisation. John has co-authored several recent publications and presentations on e-vapour products

As co-founder, first elected President (now President Emeritus) of the American E-liquid Manufacturing Standards Association (AEMSA), and launch term President of ERF, Lou serves as an unpaid consumer volunteer with no financial involvement in the industry. AEMSA is a nonprofit 501(c)(6) professional trade association establishing the world’s only self-regulation verifying e-liquid manufacturing standards. Representing AEMSA, Lou has presented before the USA FDA five times, met with OMB/OIRA, speaks at industry-leading conferences more. E-Research Foundation (soft launched November 2014) is a nonprofit designed to be an industry-wide collective funding portal to advance independent medical/scientific research targeted for peer-review and publication.

Dr. Rose is the Director of the Duke Center for Smoking Cessation and a Professor in the Department of Psychiatry and Behavioral Sciences at Duke University Medical Center. He began work in the area of tobacco addiction research as a NIMH Postdoctoral fellow at the University of California at Los Angeles. A main focus of his research program has been the elucidation of the role of sensorimotor cues and the CNS effects of nicotine in reinforcing cigarette smoking behavior. He is co-inventor of the nicotine skin patch and other treatments for smoking cessation. His primary research goals are to elucidate the biological mechanisms underlying tobacco addiction and to promote the development of more effective treatments.

Louise Ross is the Stop Smoking service manager for Leicester City, working for Leicester City Council while maintaining strong links with all NHS bodies in the area. She has worked in smoking cessation and tobacco control for over ten years. Previously she had managed a large care home for people with learning disabilities for almost 30 years, and this career change, an opportunity that disproves the theory that one needs a life-plan to be happy, has been a fantastic opportunity to influence people’s health for the better.
Initially suspicious of e-cigs, since 2013 she became a committed advocate of listening to what the general public, and Stop Smoking service users in particular, are saying about their experiences of vaping.

Gunnar Sæbø is a researcher at the National Institute for Drug Research (SIRUS) in Norway and dr.polit in Media studies from the University of Oslo. A specialist in cultural and media sociology, his projects deal with depictions of tobacco use in legislation and the media, and the influence of such depictions on behavior and public opinion.

Sæbø has published articles on tobacco use, methodology and basic issues in social science in sociological journals and been an editorial member of the Norwegian journal “Sociology today” (Sociology i dag).

Alberto Simeoni seeks for new opportunities for standardization in the Innovation Department at CEN-CENELEC, the formally recognised organizations for standardization in Europe. After having served the Italian standards body for 14 years, he supports CEN-CENELEC to attract new stakeholders and identify new ideas and needs that can be addressed by European standards and other deliverables, in coordination with the National standards bodies. Contacts with the e-cigarettes business associations resulted into the proposal to create in January 2015 the new Technical Committee - CEN/TC 437 'Electronic cigarettes and e-liquids'.

Prof Gerry Stimson is a public health social scientist, with over 40 years’ experience of public health research and advocacy in the field of psychoactive substance use. He was one of the founders of harm reduction in the 1980s, and much of his academic research focused on reducing drug and alcohol related harms. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London, and the Editor of the International Journal of Drug Policy. He founded the Department of Social Science and Medicine at Imperial College. From 1990 to 2004, he was Director of the Centre for Research on Drugs and Health Behaviour. He was Executive Director of the International Harm Reduction Association from 2004 to 2010.

Adjunct Professor, Faculty of Law, University of Ottawa
Special Lecturer, Division of Epidemiology and Public Health, University of Nottingham

David Sweanor has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked with numerous companies and organisations, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization, and currently focuses much of his efforts on risk reduction strategies. He has received both international recognition and prestigious prizes for his work.

Simon works in the IT industry as a Security Architect. He has been vaping for three years and became an advocate for ecigarettes as a result of the Welsh Government proposals to ban vaping in public enclosed spaces. He has been actively engaging politicians in Wales with a view to stopping the draconian measures proposed by the Welsh Government, attempting to open their eyes to public health prize that can be achieved through vaping.

Research interests: Social inequality in smoking and snus use, risk perceptions related to tobacco use, relationship between use of snus and smoking, historical variations in smoking. Vedøy has a PhD in sociology from the University of Oslo, focusing on the diffusion of smoking in Norway, and a Maîtrise in political philosophy from the Université Panthéon - Sorbonne in Paris.  Vedøy has been employed at the Norwegian Institute for alcohol and drug research since 2008 and is now working as a researcher on projects examining educational differences in smoking and pathways between snus use and smoking.

Dr. Monica Vialpando is the Chief Scientific Officer at Liberty Flights, a UK-based e-cigarette company. She received her Ph.D. in Pharmaceutical Sciences from KU Leuven in Belgium. Prior to this role, she worked six years in the pharmaceutical industry for U.S. and European-based companies such as Novartis and Johnson & Johnson. The emphasis of her industrial research was dedicated to formulation strategies for inhalation in both early-to late-stage drug development projects. Given Dr. Vialpando¹s background and on-going engagement within the commercial, academic, regulatory and social fields, she provides a holistic insight into vaping and its impact.

Dr Inger Wahlberg (IWG Consulting, Sweden) received her Ph.D. in chemistry in 1971 and was appointed Associated Professor in organic chemistry in 1974 at the University of Stockholm. She held various positions at the Research Department of Swedish Match for many years and worked as a scientific advisor for Swedish Match until her retirement in 2006. She has published more than 100 peer-reviewed articles in scientific journals covering tobacco chemistry and natural products chemistry in general. Inger Wahlberg is currently a consultant specialized on issues relating to tobacco and public health.

Dr Jen Ware is a Research Fellow in Molecular/Genomic Epidemiology at the University of Bristol. She is affiliated with both the Tobacco and Alcohol Research Group and the Medical Research Council Integrative Epidemiology Unit at the University of Bristol. Her research is focused largely on the development of techniques to identify and explore associations between genetic variants and drug use (including careful refinement of phenotype), and the use of Mendelian randomisation to explore causal links between drug use and a range of health and socio-economic outcomes.

Dr. Derek Yach led the development of the Framework Convention on Tobacco Control at the World Health Organization (WHO), and is currently Executive Director of the Vitality Institute, a think tank focusing on health promotion and chronic disease prevention. Derek Yach has focused his career on advancing global health and tackling tobacco control at national and international levels. He leads the Vitality Institute, an evidence-driven and action-oriented research organization founded by Discovery Holdings and dedicated to health promotion and the prevention of chronic disease to build a culture of health.

Yushu worked in pharmaceutical Industry for 21 years, which 15 years in China and 6 years in the UK. He has worked with international pharmaceutical and biotechnology companies on custom strategy for drug development and manufacturing.  He was a regular speaker in many international pharmaceutical conferences, and he was also a columnist for a leading Chinese pharmaceutical journal. Yushu is UK Chartered Marketer 2004-2015 and he is Member of Charted Institute of Marketing of UK. Yushu is a Chinese Christian.